Search Results - "Leyden, Simone"

The cost of neuroendocrine tumor patient healthcare: Comparison between advanced economies and emerging and developing economies by Gellerman, Elyse, Bouvier, Catherine, McDonnell, Mark, Rodien-Louw, Christine, Van Genechten, Dirk, Leyden, Simone, Dureja, Sugandha, Kolarova, Teodora

“…Abstract only 64 Background: The Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (SCAN) measured the delivery of healthcare to…”
Get full text

Genetic profiling analysis design of well-differentiated aggressive grade 2 and 3 gastroenteropancreatic neuroendocrine tumors in the phase III randomized controlled COMPOSE trial by Halfdanarson, Thorvardur Ragnar, Capdevila, Jaume, Halperin, Daniel M., Herrmann, Ken, Kong, Grace, Leyden, Simone, Mailman, Josh, Reidy-Lagunes, Diane, Srirajaskanthan, Rajaventhan, Erdö, Máté, Rotger, Amanda, Thevenet, Thomas

“…TPS660 Background: Deeper comprehension of gastroenteropancreatic neuroendocrine tumor (GEP-NET) characteristics has led to development of therapeutic…”
Get full text

Commonwealth Neuroendocrine Tumour Research Collaboration and the North American Neuroendocrine Tumor Society Guidelines for the Diagnosis and Management of Patients With Lung Neuroendocrine Tumors: An International Collaborative Endorsement and Update of the 2015 European Neuroendocrine Tumor Society Expert Consensus Guidelines by Singh, Simron, Bergsland, Emily K, Card, Cynthia M, Hope, Thomas A, Kunz, Pamela L, Laidley, David T, Lawrence, Ben, Leyden, Simone, Metz, David C, Michael, Michael, Modahl, Lucy E, Myrehaug, Sten, Padda, Sukhmani K, Pommier, Rodney F, Ramirez, Robert A, Soulen, Michael, Strosberg, Jonathan, Sung, Arthur, Thawer, Alia, Wei, Benjamin, Xu, Bin, Segelov, Eva

“…Lung neuroendocrine tumors (LNETs) are uncommon cancers, and there is a paucity of randomized evidence to guide practice. As a result, current guidelines from…”
Get more information

Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients (SCAN): Global disparities in quality healthcare for NETs by Van Genechten, Dirk, McDonnell, Mark, Rodien-Louw, Christine, Dureja, Sugandha, Leyden, Simone, Gellerman, Elyse, Kolarova, Teodora, Bouvier, Catherine

“…Abstract only 127 Background: Neuroendocrine tumors (NETs) are rare and complex neoplasms with increasing incidence and prevalence worldwide. SCAN assessed…”
Get full text

Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients by Dureja, Sugandha, McDonnell, Mark, Van Genechten, Dirk, Bouvier, Catherine, Kolarova, Teodora, O'Toole, Dermot, Singh, Harjit, Chen, Jie, Howe, James, Singh, Simron, Rodien‐Louw, Christine, Leyden, Simone, Gellerman, Elyse, Herman, Jackie, Pavel, Marianne

“…SCAN, an online survey, measured access to diagnosis, treatments and monitoring of neuroendocrine tumor (NET) patients globally. Between September and November…”
Get full text

Pivotal phase III COMPOSE trial will compare 177 Lu-edotreotide with best standard of care for well-differentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors by Halfdanarson, Thorvardur Ragnar, Reidy, Diane Lauren, Vijayvergia, Namrata, Halperin, Daniel M., Goldstein, Grace, Kong, Grace, Michael, Michael, Leyden, Simone, Grozinsky-Glasberg, Simona, Sorbye, Halfdan, Oberg, Kjell E., Sierras, Cristina, Harris, Philip

“…Abstract only TPS514 Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which represent approximately 70% of NETs, frequently develop…”
Get full text

Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor patients (SCAN): The diagnostic process of GEP-NETs in Australia, Canada, China, France, Germany, the United Kingdom, and the United States of America by McDonnell, Mark, Bouvier, Catherine, Pavel, Marianne E., Singh, Harjit, Howe, James R., Singh, Simron, Chen, Jie, Van Genechten, Dirk, Gellerman, Elyse, Dureja, Sugandha, Leyden, Simone, Rodien-Louw, Christine, Kolarova, Teodora, O'Toole, Dermot

“…Abstract only 502 Background: SCAN assessed the global delivery of NET diagnostics and treatment. This analysis focused on the diagnostic process in…”
Get full text

Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals by Leyden, Simone, Kolarova, Teodora, Bouvier, Catherine, Caplin, Martyn, Conroy, Siobhan, Davies, Phillipa, Dureja, Sugandha, Falconi, Massimo, Ferolla, Piero, Fisher, George, Goldstein, Grace, Hicks, Rodney J., Lawrence, Ben, Majima, Yoshiyuki, Metz, David C., O'Toole, Dermot, Ruszniewski, Philippe, Wiedenmann, Bertram, Hollander, Ronald

“…Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was…”
Get full text

Survey of challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients (SCAN): Awareness of specialized techniques and latest interventions by McDonnell, Mark, Van Genechten, Dirk, Kolarova, Teodora, O'Toole, Dermot, Singh, Harjit, Chen, Jie, Howe, James R., Singh, Simron, Bouvier, Catherine, Rodien-Louw, Christine, Leyden, Simone, Dureja, Sugandha

“…Abstract only e16708 Background: SCAN measured global readiness to provide diagnostics and treatments for NET patients in terms of awareness, availability,…”
Get full text

Treatments and ongoing monitoring for patients with neuroendocrine tumors, monitored by medical oncologists: Scan comparative data between advanced economies (AE) and emerging and developing economies (EDE) by Rodien-Louw, Christine, McDonnell, Mark, Kolarova, Teodora, Bouvier, Catherine, Pavel, Marianne E, Hicks, Rodney J., Chen, Jie, Singh, Simron, Van Genechten, Dirk, O'Toole, Dermot, Gellerman, Elyse, Dureja, Sugandha, Leyden, Simone, Howe, James R.

“…Abstract only e16200 Background: The Survey of Challenges in Access to Diagnostics and Treatment for NET Patients (SCAN) measured the delivery of healthcare to…”
Get full text

Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: 177 Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) and capecitabine plus temozolomide (CAPTEM) for pancreas and midgut neuroendocrine tumours (pNETS, mNETS)—Final results by Pavlakis, Nick, Ransom, David Turner, Wyld, David, Sjoquist, Katrin Marie, Wilson, Kate, Gebski, Val, Murray, James, Kiberu, Andrew Ddembe, Burge, Matthew E., Macdonald, William, Roach, Paul, Pattison, David A., Butler, Patrick, Price, Timothy Jay, Michael, Michael, Lawrence, Benjamin James, Bailey, Dale L., Leyden, Simone, Zalcberg, John Raymond, Turner, Harvey

“…4122 Background: CAPTEM is an accepted regimen for patients (pts) with advanced pNETs. Single agent PRRT is now a standard of care for progressive WHO Grade…”
Get full text

Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor (NET) Patients (SCAN) – application of surgery in treatment of SI NETs by Van Genechten, Dirk, McDonnell, Mark, Kolarova, Teodora, Bouvier, Catherine, Pavel, Marianne, Singh, Harjit, Singh, Simron, O’Toole, Dermot, Chen, Jie, Gellerman, Elyse, Dureja, Sugandha, Rodien-Louw, Christine, Leyden, Simone, Howe, James

Get full text

Australasian Gastrointestinal Trials Group (AGITG) CONTROL NET Study: Phase II study evaluating the activity of 177 Lu-Octreotate peptide receptor radionuclide therapy (LuTate PRRT) and capecitabine, temozolomide CAPTEM)—First results for pancreas and updated midgut neuroendocrine tumors (pNETS, mNETS by Pavlakis, Nick, Ransom, David Turner, Wyld, David, Sjoquist, Katrin Marie, Asher, Rebecca, Gebski, Val, Wilson, Kate, Kiberu, Andrew Ddembe, Burge, Matthew E., Macdonald, William, Roach, Paul, Pattison, David A., Butler, Patrick, Price, Timothy Jay, Michael, Michael, Lawrence, Benjamin James, Bailey, Dale L., Leyden, Simone, Zalcberg, John Raymond, Turner, J. Harvey

“…Abstract only 4608 Background: CAPTEM is an accepted regimen for patients (pts) with advanced pNETs. Single agent 177 Lu-Octreotate PRRT is now a standard of…”
Get full text

Access to diagnostics and treatment of neuroendocrine tumors (NETs): The difference between patient perception and reality by Leyden, Simone, Kolarova, Teodora, Bouvier, Catherine, Caplin, Martyn E., Conroy, Siobhan, Davies, Philippa, Dureja, Sugandha, Falconi, Massimo, Ferolla, Piero, Fisher, George A., Goldstein, Grace, Hicks, Rodney J., Lawrence, Benjamin James, Majima, Yoshiyuki, Metz, David C., O'Toole, Dermot, Ruszniewski, Philippe B., Wiedenmann, Bertram, Hollander, Ron

“…Abstract only e13524 Background: The aim of this global patient survey was to better understand the needs and expectations of patients with NETs regarding…”
Get full text

The Economic Impact on Australian Patients with Neuroendocrine Tumours by Gordon, Louisa G., Elliott, Thomas M., Wakelin, Kate, Leyden, Simone, Leyden, John, Michael, Michael, Pavlakis, Nick, Mumford, Jan, Segelov, Eva, Wyld, David K.

“…Background and Objective Little is known about the economic burden to patients and families with neuroendocrine tumours (NETs) for medical out-of-pocket…”
Get full text

Defining the Supportive Care Needs and Psychological Morbidity of Patients With Functioning Versus Nonfunctioning Neuroendocrine Tumors: Protocol for a Phase 1 Trial of a Nurse-Led Online and Phone-Based Intervention by Guccione, Lisa, Gough, Karla, Drosdowsky, Allison, Fisher, Krista, Price, Timothy, Pavlakis, Nick, Khasraw, Mustafa, Wyld, David, Ransom, David, Kong, Grace, Rogers, Megan, Leyden, Simone, Leyden, John, Michael, Michael, Schofield, Penelope

“…Online information resources and support have been demonstrated to positively influence the well-being of people diagnosed with cancer. This has been explored…”
Get full text

Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care by Woodhouse, Braden, Pattison, Sharon, Segelov, Eva, Singh, Simron, Parker, Kate, Kong, Grace, Macdonald, William, Wyld, David, Meyer-Rochow, Goswin, Pavlakis, Nick, Conroy, Siobhan, Gordon, Vallerie, Koea, Jonathan, Kramer, Nicole, Michael, Michael, Wakelin, Kate, Asif, Tehmina, Lo, Dorothy, Price, Timothy, Lawrence, Ben

“…Quality performance indicators (QPIs) are used to monitor the delivery of cancer care. Neuroendocrine tumours (NETs) are a family of individually uncommon…”
Get full text

Access to diagnostics and treatment of neuroendocrine tumors (NETs): The difference between patient perception and reality by Leyden, Simone, Kolarova, Teodora, Bouvier, Catherine, Caplin, Martyn E., Conroy, Siobhan, Davies, Philippa, Dureja, Sugandha, Falconi, Massimo, Ferolla, Piero, Fisher, George A., Goldstein, Grace, Hicks, Rodney J., Lawrence, Benjamin James, Majima, Yoshiyuki, Metz, David C., O'Toole, Dermot, Ruszniewski, Philippe B., Wiedenmann, Bertram, Hollander, Ron

“…Abstract only 6 Background: The aim of this global patient survey was to better understand the needs and expectations of patients with NETs regarding access to…”
Get full text